Search results
Hims & Hers Is Now Selling Semaglutide: Here's What You Should Know
Verywell Health via Yahoo Finance· 6 days agoThe program will offer compounded semaglutide to customers starting...company also plans to sell...
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
InvestorPlace· 5 days agoFor investors looking at companies providing GLP-1 drugs, there are certainly plenty of factors to...
1 in 9 US children now have ADHD, with surge in diagnoses since 2016: CDC
ABC News· 8 hours agoDiagnoses of children with attention-deficit/hyperactivity disorder (ADHD) have surged in the United...
Louisiana seeks more abortion pill controls
Politico· 6 days agoThe state’s GOP-led legislature declined to consider similar right-to-contraception legislation this year. Donald...reports. The Senate Judiciary Committee meets today at 10 a.m. to discuss ...
Does Medicare Part D Cover Prescriptions For Clinical Trials? - Canyon News
Canyon News· 5 days agoNewsroom is open 24 hours, please reach us by email at info@canyon-news.com or by phone Monday...
Former Wallingford doctor sentenced for selling opioid prescriptions
Eyewitness News 3 Hartford· 5 days agoA former doctor in Wallingford was sentenced for the illegal distribution of prescription medication...
Amid ‘Ozempic babies’ questions, women account for more than 75% of young adults taking GLP-1 drugs,...
Market Watch· 6 days agoThe total number of adolescents and young adults prescribed GLP-1 drugs, which are used to treat...
Ex-Wallingford doctor who sold opioid prescriptions for cash is sentenced
FOX61· 5 days agoA former Wallingford doctor who sold opioid prescriptions for cash was sentenced in Bridgeport on...
Patent reform could be the next big move to help bring down drug prices
Axios· 6 days agoState of play: Congress over the years has taken multiple...lawmakers say would increase competition...
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
ABC News· 6 days ago-based subsidiaries of French pharmaceutical company Sanofi. Bristol Myers Squibb and Sanofi said in a joint statement they disagreed with the penalty and plan to appeal.